Endoplasmic Reticulum Aminopeptidase-1 Functions Regulate Key Aspects of the Innate Immune Response

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Aldhamen, Yasser A ^a   Seregin, Sergey S ^a   Rastall, David P W ^a   Aylsworth, Charles F ^a   Pepelyayeva, Yuliya ^a   Busuito, Christopher J ^a   Godbehere Roosa, Sarah ^a   Kim, Sungjin ^a   Amalfitano, Andrea ^a  

^a Michigan State University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; CD11 ANTIGEN; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; INTERLEUKIN 12; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REGULATION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; LIVER CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MACROPHAGE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; OUTCOME ASSESSMENT; PHAGOCYTOSIS; PROTEIN DETERMINATION; SPLEEN CELL; WILD TYPE;

EID: 84880811634     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069539     Document Type: Article

References (69)

1. Kloetzel PM, (2004) Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat Immunol 5: 661-669.
2. Saric T, Chang SC, Hattori A, York IA, Markant S, et al. (2002) An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol 3: 1169-1176.
3. Procko E, Gaudet R, (2009) Antigen processing and presentation: TAPping into ABC transporters. Curr Opin Immunol 21: 84-91.
4. Evnouchidou I, Momburg F, Papakyriakou A, Chroni A, Leondiadis L, et al. (2008) The internal sequence of the peptide-substrate determines its N-terminus trimming by ERAP1. PLoS One 3: e3658.
5. Blanchard N, Gonzalez F, Schaeffer M, Joncker NT, Cheng T, et al. (2008) Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nat Immunol 9: 937-944.
6. York IA, Brehm MA, Zendzian S, Towne CF, Rock KL, (2006) Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc Natl Acad Sci U S A 103: 9202-9207.
7. Kim S, Lee S, Shin J, Kim Y, Evnouchidou I, et al. (2011) Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1. Nat Immunol 12: 984-991.
8. Hammer GE, Gonzalez F, James E, Nolla H, Shastri N, (2007) In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat Immunol 8: 101-108.
9. Hammer GE, Gonzalez F, Champsaur M, Cado D, Shastri N, (2006) The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat Immunol 7: 103-112.
10. Blanchard N, Kanaseki T, Escobar H, Delebecque F, Nagarajan NA, et al. (2010) Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. J Immunol 184: 3033-3042.
11. Cifaldi L, Romania P, Lorenzi S, Locatelli F, Fruci D, (2012) Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer. Int J Mol Sci 13: 8338-8352.
12. Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, et al. (2011) Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 43: 761-767.
13. Cui X, Rouhani FN, Hawari F, Levine SJ, (2003) An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. J Biol Chem 278: 28677-28685.
14. Islam A, Adamik B, Hawari FI, Ma G, Rouhani FN, et al. (2006) Extracellular TNFR1 release requires the calcium-dependent formation of a nucleobindin 2-ARTS-1 complex. J Biol Chem 281: 6860-6873.
15. Fruci D, Ferracuti S, Limongi MZ, Cunsolo V, Giorda E, et al. (2006) Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines. J Immunol 176: 4869-4879.
16. Fruci D, Locatelli F, Cifaldi L, (2012) ERAAP modulation: A possible novel strategy for cancer immunotherapy? Oncoimmunology 1: 81-82.
17. Cifaldi L, Lo Monaco E, Forloni M, Giorda E, Lorenzi S, et al. (2011) Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing. Cancer Res 71: 1597-1606.
18. Seregin SS, Aldhamen YA, Appledorn DM, Aylsworth CF, Godbehere S, et al. (2011) TRIF Is a Critical Negative Regulator of TLR Agonist Mediated Activation of Dendritic Cells In Vivo. PLoS One 6: e22064.
19. Seregin SS, Aldhamen YA, Appledorn DM, Hartman ZC, Schuldt NJ, et al. (2010) Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo. Blood 116: 1669-1677.
20. Seregin SS, Appledorn DM, McBride AJ, Schuldt NJ, Aldhamen YA, et al. (2009) Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy. Mol Ther 17: 685-696.
21. Hodges BL, Evans HK, Everett RS, Ding EY, Serra D, et al. (2001) Adenovirus vectors with the 100K gene deleted and their potential for multiple gene therapy applications. J Virol 75: 5913-5920.
22. Ng P, Graham FL, (2002) Construction of first-generation adenoviral vectors. Methods Mol Med 69: 389-414.
23. Seregin SS, Aldhamen YA, Appledorn DM, Schuldt NJ, McBride AJ, et al. (2009) CR1/2 is an important suppressor of Adenovirus-induced innate immune responses and is required for induction of neutralizing antibodies. Gene Ther 16: 1245-1259.
24. Rosenberg B, Juckett DA, Aylsworth CF, Dimitrov NV, Ho SC, et al. (2005) Protein from intestinal Eimeria protozoan stimulates IL-12 release from dendritic cells, exhibits antitumor properties in vivo and is correlated with low intestinal tumorigenicity. Int J Cancer 114: 756-765.
25. Appledorn DM, Aldhamen YA, Depas W, Seregin SS, Liu CJ, et al. (2010) A new adenovirus based vaccine vector expressing an Eimeria tenella derived TLR agonist improves cellular immune responses to an antigenic target. PLoS One 5: e9579.
26. Aldhamen YA, Seregin SS, Schuldt NJ, Rastall DP, Liu CJ, et al. (2012) Vaccines expressing the innate immune modulator EAT-2 elicit potent effector memory T lymphocyte responses despite pre-existing vaccine immunity. J Immunol 189: 1349-1359.
27. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
28. Kim S, Iizuka K, Kang HS, Dokun A, French AR, et al. (2002) In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 3: 523-528.
29. Appledorn DM, Kiang A, McBride A, Jiang H, Seregin S, et al. (2008) Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent. Gene Ther 15: 885-901.
30. Seregin SS, Amalfitano A, (2010) Improving Adenovirus Based Gene Transfer: Strategies to Accomplish Immune Evasion. Viruses 2: 2013-2036.
31. Marcoe JP, Lim JR, Schaubert KL, Fodil-Cornu N, Matka M, et al. (2012) TGF-beta is responsible for NK cell immaturity during ontogeny and increased susceptibility to infection during mouse infancy. Nat Immunol 13: 843-850.
32. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, et al. (2009) Maturation of mouse NK cells is a 4-stage developmental program. Blood 113: 5488-5496.
33. Di Santo JP, (2006) Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol 24: 257-286.
34. Hanke T, Takizawa H, McMahon CW, Busch DH, Pamer EG, et al. (1999) Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11: 67-77.
35. Yokoyama WM, Kim S, (2006) Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev. 214: 143-154.
36. Hartman ZC, Appledorn DM, Amalfitano A, (2008) Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res 132: 1-14.
37. Trinchieri G, (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146.
38. Ichikawa S, Miyake M, Fujii R, Konishi Y, (2012) MyD88 associated ROS generation is crucial for Lactobacillus induced IL-12 production in macrophage. PLoS One 7: e35880.
39. Greenberg S, Grinstein S, (2002) Phagocytosis and innate immunity. Curr Opin Immunol 14: 136-145.
40. York IA, Chang SC, Saric T, Keys JA, Favreau JM, et al. (2002) The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 3: 1177-1184.
41. Cui X, Hawari F, Alsaaty S, Lawrence M, Combs CA, et al. (2002) Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest 110: 515-526.
42. Aylsworth CF, Aldhamen YA, Seregin SS, Godbehere S, Amalfitano A (2013) Activation of human natural killer cells by the novel innate immune modulator recombinant Eimeria antigen. Hum Immunol.
43. Huntington ND, Vosshenrich CA, Di Santo JP, (2007) Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol 7: 703-714.
44. Lanier LL, (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9: 495-502.
45. Orr MT, Lanier LL, (2011) Inhibitory Ly49 receptors on mouse natural killer cells. Curr Top Microbiol Immunol 350: 67-87.
46. Garcia-Medel N, Sanz-Bravo A, Van Nguyen D, Galocha B, Gomez-Molina P, et al. (2012) Functional interaction of the ankylosing spondylitis associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo. Mol Cell Proteomics.
47. Seregin SS, Evnouchidou I, Aylsworth CF, Rastall DPW, Quiroga D, et al. (2013) Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 presentation of multiple antigens. Autoimmunity in press.
48. Newman KC, Riley EM, (2007) Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 7: 279-291.
49. Orange JS, Biron CA, (1996) An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 156: 1138-1142.
50. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C 3rd, et al (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
51. Carnaud C, Lee D, Donnars O, Park SH, Beavis A, et al. (1999) Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 163: 4647-4650.
52. De Santo C, Salio M, Masri SH, Lee LY, Dong T, et al. (2008) Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest 118: 4036-4048.
53. Gros P, Milder FJ, Janssen BJ, (2008) Complement driven by conformational changes. Nat Rev Immunol 8: 48-58.
54. Hornef MW, Wick MJ, Rhen M, Normark S, (2002) Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol 3: 1033-1040.
55. Flannagan RS, Jaumouille V, Grinstein S, (2012) The cell biology of phagocytosis. Annu Rev Pathol 7: 61-98.
56. Jiang LN, Yao CY, Jin QL, He WX, Li BQ, (2011) [The Enhanceing effect of IL-12 on phagocytosis and killing of Mycobacterium tuberculosis by neutrophils in tuberculosis patients]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 27: 1191-1194.
57. Barber GN, (2011) Cytoplasmic DNA innate immune pathways. Immunol Rev 243: 99-108.
58. Yoshida H, Okabe Y, Kawane K, Fukuyama H, Nagata S, (2005) Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat Immunol 6: 49-56.
59. Reveille JD, Sims AM, Danoy P, Evans DM, Leo P, et al. (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42: 123-127.
60. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, et al. (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39: 1329-1337.
61. Fierabracci A, Milillo A, Locatelli F, Fruci D, (2012) The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: insights from genomic-wide association studies. Autoimmun Rev 12: 281-288.
62. Harvey D, Pointon JJ, Evans DM, Karaderi T, Farrar C, et al. (2009) Investigating the genetic association between ERAP1 and ankylosing spondylitis. Hum Mol Genet 18: 4204-4212.
63. Kadi A, Izac B, Said-Nahal R, Leboime A, Van Praet L, et al. (2013) Investigating the genetic association between ERAP1 and spondyloarthritis. Ann Rheum Dis 72: 608-613.
64. Fung EY, Smyth DJ, Howson JM, Cooper JD, Walker NM, et al. (2009) Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun 10: 188-191.
65. Guerini FR, Cagliani R, Forni D, Agliardi C, Caputo D, et al. (2012) A functional variant in ERAP1 predisposes to multiple sclerosis. PLoS One 7: e29931.
66. Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, et al. (2013) Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 45: 202-207.
67. Yamamoto N, Nakayama J, Yamakawa-Kobayashi K, Hamaguchi H, Miyazaki R, et al. (2002) Identification of 33 polymorphisms in the adipocyte-derived leucine aminopeptidase (ALAP) gene and possible association with hypertension. Hum Mutat 19: 251-257.
68. Schleinitz N, Vely F, Harle JR, Vivier E, (2010) Natural killer cells in human autoimmune diseases. Immunology 131: 451-458.
69. French AR, Yokoyama WM, (2004) Natural killer cells and autoimmunity. Arthritis Res Ther 6: 8-14.